BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Drug Development

  Novartis AG Release: Six-Year Pivotal Study Data Reinforce The Superiority Of Tasigna Over Gleevec In Newly-Diagnosed Patients With Ph+ CML

  December 9, 2014

   · 

  17 min read
• BioCapital

  ACC: Study Published In American Heart Association Journal Hypertension Will Inappropriately Concern And Confuse Consumers About Bpa And Increased Blood Pressure

  December 9, 2014

   · 

  3 min read
• Drug Development

  Pharmacyclics, Inc. Release: IMBRUVICA (ibrutinib) In Combination With Rituximab Data Shows Positive Benefit-Risk Profile In Hematologic Malignancy

  December 9, 2014

   · 

  13 min read
• Business

  Wexford Science & Technology, LLC Announces 283,000 Square Foot Expansion Of Wake Forest University Baptist Medical Center Innovation Quarter

  December 9, 2014

   · 

  4 min read
• Genetown

  NeuroMetrix, Inc. To Participate In The Benchmark Micro Cap Discovery Conference

  December 9, 2014

   · 

  1 min read
• MediWound To Present At Oppenheimer 25th Annual Healthcare Conference

  December 9, 2014

   · 

  1 min read
• BioCapital

  PCORI Board Approves Providing Up To $50 Million For CER On Hepatitis C

  December 9, 2014

   · 

  3 min read
• Genetown

  Cubist Pharmaceuticals, Inc. Comments On CUBICIN Patent Litigation

  December 9, 2014

   · 

  4 min read
• Business

  ViaDerma Release: Tetrastem™ Antibiotic Continues To Demonstrate Treatment Success Leading Management To Explore Partnerships With Big Pharmaceutical Companies

  December 9, 2014

   · 

  4 min read
• Drug Development

  Celgene Release: Results From Phase 3 Study Of REVLIMID® (Lenalidomide) Demonstrating Improved Transfusion Independence In Patients With Rare Blood Cancer, Non-Del-5Q Myelodysplastic Syndromes (MDS), Presented At American Society of Hematology

  December 9, 2014

   · 

  19 min read